$GRVE
Groove Botanicals Inc

2024 Q3 Form 10-Q Financial Statement

#000117152024000304 Filed on August 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $18.33K $16.60K
YoY Change -5.67% -2.15%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $29.83K $36.54K
YoY Change 19.78% -70.53%
Operating Profit -$29.83K -$36.54K
YoY Change 19.78% -70.53%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$29.83K -$36.54K
YoY Change 8.86% -52.64%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 59.64M shares 59.64M shares 58.64M shares
Diluted Shares Outstanding 59.64M shares 59.64M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.640K $1.690K
YoY Change
Cash & Equivalents $6.133K $2.638K $1.688K
Short-Term Investments
Other Short-Term Assets $420.00 $450.00
YoY Change
Inventory
Prepaid Expenses $4.992K $416.00 $454.00
Receivables
Other Receivables $0.00
Total Short-Term Assets $11.13K $3.054K $2.142K
YoY Change 245.18% -57.01%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $11.13K $3.054K $2.142K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $11.13K $3.054K $2.142K
YoY Change 245.18% -57.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $94.93K $91.17K
YoY Change
Accrued Expenses $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $947.3K $854.8K $762.7K
YoY Change 47.49% 65.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $947.3K $854.8K $762.7K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $947.3K $854.8K $762.7K
YoY Change 47.49% 65.71%
SHAREHOLDERS EQUITY
Retained Earnings -$35.02M -$34.94M -$34.85M
YoY Change 1.13% 1.25%
Common Stock $59.64K $59.64K $59.64K
YoY Change 1.71% 3.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$936.2K -$851.7K -$760.6K
YoY Change
Total Liabilities & Shareholders Equity $11.13K $3.054K $2.142K
YoY Change 245.18% -57.01%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$29.83K -$36.54K
YoY Change 8.86% -52.64%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$20.74K -$30.08K
YoY Change -36.68%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $21.69K 29.62K
YoY Change -29.01%
NET CHANGE
Cash From Operating Activities -$20.74K -30.08K
Cash From Investing Activities 0.000
Cash From Financing Activities $21.69K 29.62K
Net Change In Cash $950.00 -460.0
YoY Change -143.18%
FREE CASH FLOW
Cash From Operating Activities -$20.74K -$30.08K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2024Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2024Q2 grve Stock Issued For Outside Services
StockIssuedForOutsideServices
usd
CY2024Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
310 Fourth Avenue South
CY2024Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 7000
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Minneapolis
CY2024Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55415
CY2024Q2 dei City Area Code
CityAreaCode
(612)
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
315-5068
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59643062 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2638 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1688 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
416 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
454 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
3054 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2142 usd
CY2024Q2 us-gaap Assets
Assets
3054 usd
CY2024Q1 us-gaap Assets
Assets
2142 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
94929 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
91172 usd
CY2024Q2 grve Related Party Payable Current
RelatedPartyPayableCurrent
486751 usd
CY2024Q1 grve Related Party Payable Current
RelatedPartyPayableCurrent
453057 usd
CY2024Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
273087 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
218470 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
762699 usd
CY2024Q1 us-gaap Liabilities
Liabilities
762699 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59643062 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59643062 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59643062 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59643062 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
59643 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34026869 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34847277 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-760557 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2142 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16599 usd
CY2024Q2 grve Rent
Rent
4644 usd
CY2023Q2 grve Rent
Rent
4644 usd
CY2024Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
14546 usd
CY2023Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
24070 usd
CY2024Q2 grve Consulting Expense
ConsultingExpense
750 usd
CY2023Q2 grve Consulting Expense
ConsultingExpense
78300 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
36539 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
123977 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-36539 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-123977 usd
CY2023Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2250 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2250 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-36539 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-126227 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
54617 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
54618 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-91156 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-180845 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59643062 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59643062 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58478227 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58478227 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-438298 usd
CY2023Q2 grve Issuance Of Stock For Consulting
IssuanceOfStockForConsulting
78300 usd
CY2023Q2 grve Accrued Dividend To Related Party
AccruedDividendToRelatedParty
-54618 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-126227 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-540843 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-760557 usd
CY2024Q2 grve Accrued Dividend To Related Party
AccruedDividendToRelatedParty
-54617 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-36539 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-851713 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-36539 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-126227 usd
CY2023Q2 grve Stock Issued For Outside Services
StockIssuedForOutsideServices
-78300 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2250 usd
CY2024Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12000 usd
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12000 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-38 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-41 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3757 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
878 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20744 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32758 usd
CY2024Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
21694 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30558 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21694 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30558 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
950 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2200 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1688 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4566 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2638 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2366 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_z1eoFOmnuDYc" style="font: 11pt Times New Roman,serif; margin: 0"><span id="xdx_860_zsUAUfTL1ZV">Use of Estimates</span></p> <p style="font: 11pt Times New Roman,serif; margin: 0"> </p> <p style="font: 11pt Times New Roman,serif; margin: 0 1.3pt 0 0; text-align: justify; text-indent: -0.45pt">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, such estimates were made by the Company for the valuation of derivative liability, stock compensation and beneficial conversion feature expenses. Actual results could differ from those estimates.</p> <p style="font: 11pt Times New Roman,serif; margin: 0">Financial Instruments</p> <p style="font: 11pt Times New Roman,serif; margin: 0"> </p> <p style="font: 11pt Times New Roman,serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: -0.7pt">The Company's financial instruments primarily consist of cash and cash equivalents, accounts payable and accrued liabilities, related party payables, dividends payable and other debt. The carrying values of the Company's financial instruments approximate fair value. FASB ASC 820, Fair Value Measurements and Disclosures ("ASC 820") establishes a framework for all fair value measurements and expands disclosures related to fair value measurement and developments. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 requires that assets and liabilities measured at fair value are classified and disclosed in one of the following three categories: Level 1—Quoted market prices for identical assets or liabilities in active markets or observable inputs; Level 2—Significant other observable inputs that can be corroborated by observable market data; and Level 3—Significant unobservable inputs that cannot be corroborated by observable market data. The Company believes that the carrying amounts of cash and cash equivalents, accounts payable, related party payables, accrued dividends and debt approximate fair value based on either their short-term nature or on terms currently available to the Company in financial markets.</p> <p style="font: 11pt Times New Roman,serif; margin: 0 0 0 0.7pt; text-align: justify; text-indent: -0.7pt"> </p>
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-36539 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-126227 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34938433 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34847277 usd
CY2024Q2 grve Related Party Payment Outstanding
RelatedPartyPaymentOutstanding
486751 usd
CY2024Q1 grve Related Party Payment Outstanding
RelatedPartyPaymentOutstanding
453057 usd
CY2022Q2 grve Related Party Debt
RelatedPartyDebt
125000 usd
CY2024Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
500000 usd
CY2024Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
5000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59643062 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59643062 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59643062 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59643062 shares
CY2024Q2 grve Verbal Lease Agreement Description
VerbalLeaseAgreementDescription
Company has a month-to-month verbal lease agreement with the landlord, in which the Company pays $1,200 on a monthly basis.

Files In Submission

Name View Source Status
0001171520-24-000304-index-headers.html Edgar Link pending
0001171520-24-000304-index.html Edgar Link pending
0001171520-24-000304.txt Edgar Link pending
0001171520-24-000304-xbrl.zip Edgar Link pending
eps11490_grve.htm Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grve-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
grve-20240630_cal.xml Edgar Link unprocessable
grve-20240630_def.xml Edgar Link unprocessable
grve-20240630_lab.xml Edgar Link unprocessable
grve-20240630_pre.xml Edgar Link unprocessable
eps11490_grve_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending